Grace Therapeutics GRCE
NASDAQ GRCE
$2.15 +0.04 (+1.90%)
At close: Sep 30, 2026 · 4:00 PM EDT

Grace Therapeutics (GRCE) Gross Profit (2020 - 2021)

Updated

Grace Therapeutics (GRCE) posted Gross Profit of $75,000 for fiscal Q4 2021 (quarter ended Mar 31, 2021), up 66.7% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Gross Profit (2020 - 2021) Analysis & Trends

For FY2021 (ended Mar 31, 2021), Grace Therapeutics' Gross Profit came in at $120,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Grace Therapeutics 34.99 Mn 34.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 75,000.00
Dec 31, 2020 45,000.00
API Access

Grace Therapeutics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=GRCE&period=max&api_key=YOUR_API_KEY